New shot aims to restore skin color in vitiligo patients
NCT ID NCT06625177
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests a new drug called TEV-53408 in 38 adults with vitiligo. The main goal is to see if the drug is safe when given as a shot under the skin. Researchers will also look for early signs that it might help bring back skin color. The study lasts 84 weeks, including treatment, a washout period, and follow-up.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
TEV-53408 injection
What this could lead to
If it works, this could point toward a new treatment option to help restore skin color in people with vitiligo.
What could go wrong
This is a very early, small Phase 1b trial focused on safety, not proof of effectiveness. The drug may not work or could have side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Teva Investigational Site 12043
Scottsdale, Arizona, 85260, United States
-
Teva Investigational Site 12044
Fremont, California, 94538, United States
-
Teva Investigational Site 12045
Dallas, Texas, 75230, United States
-
Teva Investigational Site 12046
Pasadena, California, 91101, United States
-
Teva Investigational Site 12047
Chicago, Illinois, 60614, United States
-
Teva Investigational Site 12048
Canton, Michigan, 48187, United States
-
Teva Investigational Site 12049
Miramar, Florida, 33025, United States
-
Teva Investigational Site 12051
Irvine, California, 92617, United States
-
Teva Investigational Site 12052
Hot Springs, Arkansas, 71913, United States
-
Teva Investigational Site 12053
Louisville, Kentucky, 40421, United States
-
Teva Investigational Site 12054
Portland, Oregon, 97210, United States
-
Teva Investigational Site 12055
South Jordan, Utah, 84095, United States
-
Teva Investigational Site 12057
Webster, Texas, 77598, United States